Predictors of High-Burden Residual Axillary Disease After Neoadjuvant Therapy in Breast Cancer
Identifying patients at risk of high-burden residual axillary disease is essential to optimize neoadjuvant strategies. Increasing axillary pathological complete response may reduce the need for ALND, minimizing surgical morbidity without compromising oncological outcomes.
Authors
- Andrea Sagona (ORCID: https://orcid.org/0000-0002-4372-9921)
- Simone Di Maria Grimaldi (ORCID: https://orcid.org/0000-0002-1014-0141)
- E. Barbieri (ORCID: https://orcid.org/0000-0002-4980-3985)
- Damiano Gentile (ORCID: https://orcid.org/0000-0002-8861-5223)
- Corrado Tinterri (ORCID: https://orcid.org/0000-0002-7272-3924)
- Jacopo Canzian (ORCID: https://orcid.org/0009-0008-0883-0582)
Institutions
- Humanitas University (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Cancers
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3390/cancers17101596
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94